Linus Health

What Linus Health does

Linus Health is a Boston-based digital health company that has built an AI-driven cognitive assessment platform for the early detection of cognitive impairment and Alzheimer's disease. The company's core technology combines process-based machine learning with multimodal signal detection (digital stylus drawing data from DCTclock and DCR assessments, speech analytics from Aural Analytics, and physical function data from Kinesis Health Technologies) to generate hundreds of precise metrics from assessments that take approximately 7 minutes, claiming accuracy comparable to 3-hour neuropsychological evaluations. The flagship product, the Core Cognitive Evaluation (CCE), integrates the Digital Clock and Recall test with the Life and Health Questionnaire, and is delivered alongside add-on modules such as the Anywhere remote assessment platform, the RADAR predictive algorithm for payers, the ePSOM person-specific outcome measure for clinical trials, and the Moving Together intervention program from Together Senior Health.

The company sells primarily through an enterprise field sales motion targeting four customer segments: health systems and hospitals (standardized cognitive testing, care coordination, and EHR-integrated workflows), medical practices (early detection at the primary care level), life sciences companies (clinical trial recruitment, safety endpoint monitoring, and outcomes measurement for Alzheimer's, Parkinson's, and ALS studies), and payers/health plans (risk stratification, HCC capture, and RAF score optimization). Pricing is quote-based enterprise SaaS on annual or multi-year subscriptions, with channel expansion now underway through a first-of-its-kind supplier agreement with Provista, a major healthcare group purchasing organization. The platform is FDA-listed, CE-marked, UKCA-marked, EU Class IIa under MDR, ISO 13485 certified, HIPAA and GDPR compliant, and SOC 2 Type 2 certified, and is integrated with Epic, Cerner, Athenahealth, Oracle Health, Xealth, and SMART on FHIR, supporting deployment within the dominant US EHR ecosystems. The company has delivered 225,000+ cognitive assessments, supported 60+ clinical trials, and accumulated 160+ peer-reviewed publications validating its technology.

Name

Linus Health

Legal name

Linus Health, Inc.

Website

https://linushealth.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

101–250 employees

Short description

Linus Health is a Boston-based digital health company that sells an AI-driven cognitive assessment platform to health systems, medical practices, life sciences companies, and payers for early detection of Alzheimer's and cognitive impairment, having delivered 225,000+ assessments and 60+ clinical trials.

Ownership category

akta.pro rank

Product category

Digital Cognitive Assessment Platform

NAICS

Software Publishers (5132)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)

akta.pro secondary industries

eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Neurology RPM (epilepsy, Parkinson’s, MS monitoring) (HLALAFAJ)

Keywords

• Digital cognitive assessment
• Alzheimer's early detection
• Brain health platform
• Clinical trial outcomes
• Healthcare analytics software

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Healthcare Provider Subscriptions: Annual or multi-year subscription licensing of digital cognitive assessment platform to health systems, hospitals, and physician practices. Includes EHR integrations, assessment tools, and reporting capabilities.
2. Life Sciences / Clinical Trial Services: Providing digital assessment tools and services to pharmaceutical companies for clinical trial recruitment, safety endpoint monitoring, and outcomes measurement. Supports Alzheimer's, Parkinson's, ALS, and mental health clinical trials.
3. Payer Risk Stratification: Platform services for health plans to identify at-risk members, support HCC capture, and optimize RAF scores for risk adjustment.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Linus Health sells an AI-driven digital cognitive assessment platform that uses multimodal signal detection and machine learning to analyze drawing behavior, speech characteristics, and other digital biomarkers for early detection of cognitive impairment and Alzheimer's disease. The platform is licensed primarily through annual subscriptions to health systems, medical practices, payers, and life sciences companies, with EHR integrations and remote assessment capabilities. It includes flagship offerings such as the Core Cognitive Evaluation (CCE), DCTclock, DAC, the Anywhere remote assessment platform, and the RADAR risk-stratification algorithm.

Product overview

Linus Health offers a digital cognitive assessment platform consisting of multiple integrated products and modules. The core platform centers on the Core Cognitive Evaluation (CCE), which combines the Digital Clock and Recall (DCR) and Life and Health Questionnaire (LHQ). Key products include the award-winning DCTclock, Digital Assessment of Cognition (DAC), and the remote assessment capability (Anywhere). The company has expanded through acquisitions including Kinesis Health Technologies (physical function assessment), Aural Analytics (speech analytics), and Together Senior Health (care programs including Moving Together and RADAR). The platform provides over a dozen cognitive assessments including drawing tests, speech analysis, trail making tests, and functional assessments, all processed through AI/ML algorithms that capture hundreds of precise metrics to detect cognitive impairment earlier than traditional methods.

Differentiator

Problem solved

Functional benefit

Brands

• DCTclock: Award-winning digital cognitive assessment tool that generates insights from the drawing process itself using iPad-based technology
• DCR (Digital Clock and Recall)
• DAC (Digital Assessment of Cognition)
• CCE (Core Cognitive Evaluation)
• Anywhere for Health Systems
• rDAC
• ePSOM
• RADAR

Products and services

• Core Cognitive Evaluation (CCE)
• Digital Clock and Recall (DCR)
• DCTclock
• Digital Assessment of Cognition (DAC)
• Anywhere powered by Linus Health
• Moving Together Program
• RADAR Algorithm
• ePSOM (electronic Person-Specific Outcome Measure)
• Kinesis Health Technologies (QTUG and Kinesis Gait)

Quantifiable outcome

• 90.7% sensitivity and 100% specificity for distinguishing cognitively unimpaired from impaired individuals (DAC)
• +4 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability8 records

Feature7 records

Partnerships

Twelve partnerships are on record, tiered major, core, flagship, strategic and minor.

• Global Alzheimer's Platform Foundation (GAP)majorStrategic or Co-development Partner · 18 May 2026GAP announced Sanofi as partner in Bio-Hermes-002 observational study evaluating blood-based and digital biomarkers. Linus Health's digital biomarkers included alongside pharmaceutical partners Biogen, Eli Lilly, Roche.
• ProvistacoreChannel Partner/ Reseller/ Distributor · 26 March 2026Leading group purchasing organization. Supplier agreement makes Linus Health the first AI-driven brain health solution selected by Provista, expanding access to physician practice clients nationwide.
• Together Senior HealthcoreStrategic or Co-development Partner · 24 July 2024Brain health company offering Moving Together program and RADAR algorithm for improving patient outcomes and reducing healthcare costs through physical activity interventions.
• Aural AnalyticscoreStrategic or Co-development Partner · 1 March 2024Acquired to strengthen digital cognitive assessment platform with advanced speech analytics for early detection of cognitive impairments.
• Kinesis Health TechnologiescoreStrategic or Co-development Partner · 30 March 2022Dublin-based company specializing in physical assessment tools for older adults. Kinesis brings sensor technology for gait, balance, and mobility assessment to enhance Linus Health's early detection capabilities. Acquired by Linus Health; key leadership retained.
• Davos Alzheimer's CollaborativeflagshipStrategic or Co-development PartnerInternational initiative for early detection of Alzheimer's. Linus technology deployed at seven flagship pilot sites to measurably increase timely, accurate diagnosis.
• Emory HealthcaremajorStrategic or Co-development PartnerEmory deploying Linus digital cognitive assessments to expand early detection of Alzheimer's and other dementias. Partnership supports standardization of cognitive screening in primary care.
• Indiana University School of MedicinemajorStrategic or Co-development PartnerIU physicians and researchers using Linus screening tools for early detection of Alzheimer's as part of Davos Alzheimer's Collaborative initiative.
• Health Innovation ManchestermajorStrategic or Co-development PartnerUK partnership launching cognitive impairment case-finding program across Greater Manchester region to improve early detection in primary care.
• DATAcc by DiMe (Digital Medicine Society)strategicStrategic or Co-development PartnerCollaboration with 20+ industry partners to develop digital measures for mental health disorders. Seven measures including cognitive function and speech/language changes using digital health technologies.
• Digital Medicine Society (DiMe)strategicStrategic or Co-development PartnerDiMe launched Connected Health Collaborative initiative for tech-enabled aging at home, with Linus Health as coalition partner to develop evidence-based blueprint for older adults.
• Brook HealthminorStrategic or Co-development PartnerPartnership for cognitive care assessment combining Brook Health services with Linus Health digital cognitive assessment tools.

Scale indicators7 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Cogstate: Public digital cognitive assessment company offering computerized tests and eCOA solutions for clinical trials and healthcare — directly comparable to Linus's DCTclock/DAC and life-sciences segment, including similar pharma trial endpoint services.
• Cambridge Cognition: Digital health company specializing in cognitive assessments for CNS clinical trials and clinical practice, with validated endpoints used by major pharma — overlapping directly with Linus's CCE/DCR and life-sciences business.
• Altoida: Digital biomarker company using augmented reality and AI on smartphones/tablets to detect cognitive impairment — directly comparable in patient-facing, multimodal digital cognitive assessment with FDA breakthrough designation.
• BrainCheck: Digital cognitive assessment platform serving health systems and physicians with rapid screening tools and EHR integration — direct competitor in primary-care and specialty cognitive screening workflows.
• Neurotrack: Digital cognitive health company offering assessment-based tools for early detection of memory impairment and dementia risk — comparable in consumer and provider-facing cognitive screening.
• BioSensics: Developer of wearable sensors and digital outcome measures for gait, balance, and physical function in older adults — directly comparable to the Kinesis Health Technologies business Linus acquired.

Emerging players

• Cumulus Neuroscience: Clinical-stage digital brain health platform combining at-home cognitive and speech assessments with biomarker endpoints for CNS trials — emerging player in the same multimodal-assessment space.
• CeriBell: AI-driven neurology diagnostics platform using EEG and cloud analytics in clinical settings — adjacent digital neurology SaMD competitor with overlapping neurology customer base.

Broad incumbents

• Click Therapeutics: Prescription digital therapeutics (DTx) company developing FDA-cleared SaMD for neurology and psychiatry — broader SaMD/DTx incumbent with adjacent regulatory and commercial pathways.
• Pear Therapeutics (terapeutics-style DTx peers): Digital therapeutics and digital care companies (e.g., Big Health) operating in adjacent brain/mental-health condition management — overlapping in DTx distribution models and payer engagement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/linus-health
• Instagraminstagram.com/linus.health

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries4 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Linus Health